Mohajeri E, Kalantari-Khandani B, Pardakhty A, Safavi M, Ansari M. Comparative pharmacokinetic evaluation and bioequivalence study of three different formulations of Imatinib Mesylate in CML patients. Int J Hematol Oncol Stem Cell Res. 2016;9(4):165-172.